Loading clinical trials...
Loading clinical trials...
Pseudohypoparathyroidism is a genetic disorder with limited treatment options, characterized by early-onset obesity, short stature, hormone resistance and cognitive impairment. This phase 2 clinical t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ashley Shoemaker
NCT05945576 · Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, and more
NCT03029429 · Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy
NCT02551120 · Idiopathic Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and more
NCT02463409 · Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy
NCT00497484 · Pseudohypoparathyroidism, Growth Hormone Deficiency, Dwarfism
Vanderbilt University Medical Center
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions